Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy.
Sagawa Y, Nagata Y, Yamaguchi T, Mitsui K, Nagamine T, Yamaguchi J, Hijikata S, Watanabe K, Masuda R, Miyazaki R, Kaneko M, Miwa N, Sekigawa M, Hara N, Nozato T, Ashikaga T, Goya M, Sasano T, Hirao K.
Sagawa Y, et al. Among authors: ashikaga t.
Int Heart J. 2020 Jan 31;61(1):39-45. doi: 10.1536/ihj.19-279. Epub 2020 Jan 17.
Int Heart J. 2020.
PMID: 31956141
Free article.